Bank Of Nova Scotia Sage Therapeutics, Inc. Transaction History

Bank Of Nova Scotia

  • $47.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022
BUY
$27.52 - $37.99 $2.39 Million - $3.31 Million
87,000 New
87,000 $2.81 Million
Q1 2022

May 09, 2022
SELL
$30.71 - $45.71 $1.35 Million - $2.01 Million
-44,032 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$37.06 - $47.11 $1.63 Million - $2.07 Million
44,032 New
44,032 $1.87 Million

Others Institutions Holding SAGE

# of Institutions
198
Shares Held
46.5M
Call Options Held
402K
Put Options Held
209K
View Full List

About Sage Therapeutics, Inc.

SAGE Quotes by TradingView
  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Bank Of Nova Scotia Portfolio

Follow Bank Of Nova Scotia and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email